» Articles » PMID: 39329151

Establishment of an Inflammatory Bowel Disease Model Using Immunological Differentiation of Caco-2 Cells

Overview
Journal MethodsX
Specialty Pathology
Date 2024 Sep 27
PMID 39329151
Authors
Affiliations
Soon will be listed here.
Abstract

Studies on intestinal cell differentiation, particularly in dextran sodium sulfate (DSS)-induced inflammatory bowel disease (IBD), have predominantly focused on the disruption of intestinal crypts and suppressive effects on the intestinal microbiota; however, repeated administration of DSS is required to induce inflammatory pathology, and there is a lack of observation of early responses and consideration of differentiation stages. Although colonic adenocarcinoma (Caco-2) cells can be used as intestinal cell models, research on these cells in an immature state is limited. We, therefore, investigated the relationship between Caco-2 cell culture duration and immunological differentiation using α-defensin5 (DEFA5) as an indicator of intestinal immunity and differentiation. Changes in protein and gene expression levels in response to DSS were examined at each differentiation stage. Expression of immune- and differentiation-related proteins, including DEFA5 and lysozyme, was evident from Day 8 of culture. Immune responses to DSS varied with the differentiation stage, affecting cell viability and cytokine expression.•Caco-2 cell culture duration correlates with the differentiation stage of Paneth cells.•DSS exposure elicits different effects depending on the differentiation stage.•Our model of IBD facilitates the characterization of the cell differentiation process and provides a methodology to help elucidate the causal mechanisms of IBD.

References
1.
Takenaka T, Harada N, Kuze J, Chiba M, Iwao T, Matsunaga T . Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer. J Pharm Sci. 2016; 105(2):915-924. DOI: 10.1016/j.xphs.2015.11.035. View

2.
Tsuruta S, Kawasaki T, Machida M, Iwatsuki K, Inaba A, Shibata S . Development of Human Gut Organoids With Resident Tissue Macrophages as a Model of Intestinal Immune Responses. Cell Mol Gastroenterol Hepatol. 2022; 14(3):726-729.e5. PMC: 9421619. DOI: 10.1016/j.jcmgh.2022.06.006. View

3.
Reyes E, Castillo-Azofeifa D, Rispal J, Wald T, Zwick R, Palikuqi B . Epithelial TNF controls cell differentiation and CFTR activity to maintain intestinal mucin homeostasis. J Clin Invest. 2023; 133(20). PMC: 10575728. DOI: 10.1172/JCI163591. View

4.
Bilsborough J, Fiorino M, Henkle B . Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov. 2020; 16(5):567-577. DOI: 10.1080/17460441.2021.1851185. View

5.
Tschurtschenthaler M, Kachroo P, Heinsen F, Adolph T, Ruhlemann M, Klughammer J . Paternal chronic colitis causes epigenetic inheritance of susceptibility to colitis. Sci Rep. 2016; 6:31640. PMC: 4990911. DOI: 10.1038/srep31640. View